Dividend Watching: Tekla Healthcare Investors (NYSE:HQH) expects Dec 30, 2016 to be an important day for investors.

Dividend Watching: Tekla Healthcare Investors (NYSE:HQH) expects Dec 30, 2016 to be an important day for investors.

Tekla Healthcare Investors (NYSE:HQH) is expected to pay $0.50 on Dec 30, 2016. The indicated annual dividend is $1.95. Shareholders owning the stock before Nov 23, 2016 will be eligible to receive the payout. Based on Tekla Healthcare Investors’s current price of $23.79, the dividend is 2.10%. This dividend’s record date is Nov 28, 2016 and the announcement date is Nov 21, 2016. The stock decreased 0.21% or $0.05 on November 21, hitting $23.79. Tekla Healthcare Investors (NYSE:HQH) has declined 4.57% since April 20, 2016 and is downtrending. It has underperformed by 9.13% the S&P500.

Tekla Healthcare Investors , formerly H&Q Healthcare Investors, is a diversified closed-end management investment company. The company has a market cap of $906.35 million. The Fund’s investment objective is long-term capital appreciation through investment in the United States and foreign companies in the healthcare industry. It currently has negative earnings. The Fund invests primarily in securities of public and private companies.

Insitutional Activity: The institutional sentiment increased to 1.33 in Q2 2016. Its up 0.37, from 0.96 in 2016Q1. The ratio is positive, as 6 funds sold all Tekla Healthcare Investors shares owned while 22 reduced positions. 11 funds bought stakes while 16 increased positions. They now own 6.22 million shares or 12.31% less from 7.09 million shares in 2016Q1.
Doliver Advsrs Inc has 0.82% invested in the company for 40,308 shares. Bartlett Ltd Liability Corp last reported 8,623 shares in the company. Thrivent For Lutherans reported 16 shares or 0% of all its holdings. Finemark Commercial Bank And Trust accumulated 211 shares or 0% of the stock. Fuller Thaler Asset Mgmt Inc accumulated 0% or 1 shares. Advisory Ser Network Limited Liability holds 1,135 shares or 0.01% of its portfolio. Moreover, Dubuque Fincl Bank And Tru has 0.01% invested in Tekla Healthcare Investors (NYSE:HQH) for 2,122 shares. Regis Mgmt Lc accumulated 16,386 shares or 0.08% of the stock. The Connecticut-based Newgate has invested 1.21% in Tekla Healthcare Investors (NYSE:HQH). Guardian has 0% invested in the company for 2,144 shares. Pennsylvania Tru holds 0.03% of its portfolio in Tekla Healthcare Investors (NYSE:HQH) for 17,636 shares. Stifel Fincl Corp last reported 87,439 shares in the company. Bancshares Of Montreal Can has invested 0% of its portfolio in Tekla Healthcare Investors (NYSE:HQH). The New York-based Brown Brothers Harriman And has invested 0% in Tekla Healthcare Investors (NYSE:HQH). Tfs Cap Ltd Liability holds 9,511 shares or 0.04% of its portfolio.

More notable recent Tekla Healthcare Investors (NYSE:HQH) news were published by: Businesswire.com which released: “H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Name Changes” on October 15, 2014, also Nasdaq.com with their article: “Tekla Healthcare Investors (HQH) Ex-Dividend Date Scheduled for May 22, 2015” published on May 21, 2015, Seekingalpha.com published: “Investing In Biotech: Tekla CEFs Or IBB?” on September 24, 2015. More interesting news about Tekla Healthcare Investors (NYSE:HQH) were released by: Businesswire.com and their article: “Tekla Capital Management LLC Successfully Launches Tekla World Healthcare Fund” published on June 30, 2015 as well as Seekingalpha.com‘s news article titled: “THQ: This New Healthcare CEF Looks Positioned To Move Higher” with publication date: March 19, 2015.

HQH Company Profile

Tekla Healthcare Investors (the Fund), formerly H&Q Healthcare Investors, incorporated on October 31, 1986, is a registered investment adviser based in Boston, Massachusetts and is currently the investment adviser for three closed-end equity funds, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors and Tekla Life Sciences Investors. The Funds invest in growth equities, both public and private, debt and pooled investment vehicles, in the healthcare and life sciences industries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment